Istituto di Ricerche Farmacologiche Mario Negri

Organisation

Trials

NCT07813858
Collaborator, Phase 2, Not yet recruiting, 87 people, 10 Sept 2026
NCT07274384
Collaborator, Phase 2, Not yet recruiting, 74 people, 10 Dec 2025
NCT05601700
Collaborator, Phase 3, Recruiting, 132 people, 1 Nov 2022
NCT05014581
Collaborator, Phase 3, Recruiting, 420 people, 20 Aug 2021
NCT04776655
Collaborator, Phase 3, Active, not recruiting, 280 people, 2 Mar 2021
NCT03654105
Collaborator, Phase 2, Active, not recruiting, 2,000 people, 31 Aug 2018
NCT03462212
Collaborator, Phase 1/2, Status unknown, 290 people, 12 Mar 2018
NCT02040441
Collaborator, Phase 2/3, Completed, 1,777 people, 20 Jan 2014

European Commission
HORIZON-RIA, Accelerating Tobacco Cessation within Healthcare Systems of European LMICs: A Multi-Country Implementation-Effectiveness Trial, 101288379, €401.7k, 2026–2031, 18 May 2026
European Commission
HORIZON-IA, Fully automated cell and tissue-engineered bioimplant production for orocraniofacial regeneration, 101286740, €243.3k, 2026–2030, 12 May 2026